MADISON, N.J.--(BUSINESS WIRE)--As part of a nationwide effort to help communities fight congestion, Pfizer Consumer Healthcare, the makers of Advil® Congestion Relief, is partnering with local organization, CURE, to refurbish a trolley to be used to safely shuttle area youth to and from afterschool activities. Prior to the addition of this trolley, the program couldnt accommodate all interested students due to lack of space on its buses. This season, Advil® Congestion Relief has made its tagli

CHICAGO--(BUSINESS WIRE)--One in five adults over the age of 20 in the United States has high cholesterol1, which is a major risk factor for cardiovascular disease, including heart attack and stroke. Eighty-eight percent of Illinois residents have at least one risk factor for cardiovascular disease2. Pfizer and Walgreens are showing Chicagoans how easy and convenient it can be to shop for and prepare meals that are low in cholesterol and fat as well as snacks to support a healthy lifestyle. Mas

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 1, 2012. The purpose of the call is to provide an update on Pfizers results, as reflected in the companys First Quarter 2012 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com and click on the Pfizer Quarterl

NEW YORK--(BUSINESS WIRE)--Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizers early-stage compounds, including data from Pfizers investigational antibody-drug conjugate (ADC) portfolio and research evaluating several molecules targeting novel pathways that play a crucial role in basic cellular functions, at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, IL, from March 31-April 4. The data we will present at AACR

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced additional analyses from the ARISTOTLE and AVERROES clinical trials will be presented at the American College of Cardiologys 61st Annual Scientific Session, March 24-27, 2012, in Chicago. The two large Phase 3 clinical trials compared ELIQUIS® (apixaban), an investigational compound for the prevention of stroke or systemic embolism in patients with nonvalvular atrial

KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--As an official partner of the First World Congress on Healthy Ageing, Pfizer reaffirms the companys commitment to promote healthy and active ageing at all stages of life as a basis for enhanced productivity in the Asia Pacific. Pfizer will lead a luncheon symposium today focused on the relationship between health and economic sustainability and the resulting challenges and opportunities of shifting demographics across the region. We are seeing an explos